PBA Use for Treatment of ATF6-/- Patients
Condition(s):ACHROMATOPSIA 7; AchromatopsiaLast Updated:March 17, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):ACHROMATOPSIA 7; AchromatopsiaLast Updated:March 17, 2023Not yet recruiting
Condition(s):Color Vision Defects; Color BlindnessLast Updated:December 8, 2022Completed
Condition(s):AchromatopsiaLast Updated:June 27, 2023Completed
Condition(s):CAD Test; Children’s Vision; Colour Assessment; Colour Vision; TurkeyLast Updated:August 9, 2019Completed
Condition(s):AchromatopsiaLast Updated:December 1, 2022Completed
Condition(s):AchromatopsiaLast Updated:March 15, 2024Active, not recruiting
Condition(s):Color Blindness, Red; Reaction TimeLast Updated:March 31, 2020Completed
Condition(s):Visual Suppression; Amblyopia; Color Vision DefectsLast Updated:July 20, 2023Suspended
Condition(s):AchromatopsiaLast Updated:March 8, 2023Completed
Condition(s):AchromatopsiaLast Updated:July 22, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.